Advertisement

Topics

Ovarian Cancer Coalition of Greater California Company Profile

06:35 EDT 21st September 2017 | BioPortfolio


News Articles [6708 Associated News Articles listed on BioPortfolio]

The National Ovarian Cancer Coalition Announces 2018 Conference to be Held in New York City

The NOCC will bring together top professionals from the ovarian cancer space together in New York City, April 27-29, 2018 Dallas, Texas (PRWEB) May 08, 2017 The National Ovarian Cancer Coalition, the...

Have a Question about Genetic Testing and Ovarian Cancer? Join us on September 28th!

The National Ovarian Cancer Coalition Presents: Genetic Testing and Ovarian Cancer – It’s Personal Live Webinar on Thursday, September 28th […] The post Have a Question about Genetic Testing...

The National Ovarian Cancer Coalition Kicks Off Ovarian Cancer Awareness Month By Ringing the Opening Bell at NASDAQ

DALLAS, TX (PRWEB) September 01, 2017 The NOCC kicked-off September Ovarian Cancer Awareness Month in a big way by ringing the ope...

Study sheds light on how ovarian cancer spreads

With 20,000 diagnoses each year, ovarian cancer is the ninth most common cancer and fifth leading cause of cancer death among women in the United States. So many women die from ovarian cancer because ...

Ovarian Cancer Clinical Trials: What, Where, Why

Pre-recorded webinar on Thursday, July 13th, 7–8 p.m. EST Have questions about ovarian cancer clinical trials? Join the National Ovarian […] The post Ovarian Cancer Clinical Trials: What, Wher...

Epithelial Ovarian Cancer Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $2000

DelveInsight's, Epithelial Ovarian Cancer Pipeline Insights, 2017, report provides comprehensive insights about pipeline drugs across this Epithelial Ovarian Cancer. The key objective of the report i...

Epithelial Ovarian Cancer Epidemiology Insights to 2025 [Report Updated: 10072017] Prices from USD $2950

DelveInsight Epithelial Ovarian Cancer Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Epithelial Ovarian Cancer in seven major markets US, France, Germany, Italy, S...

Risk factors, symptoms, diagnosis and treatment of ovarian cancer

Ovarian cancer is the 9th most common cancer in women and although it only accounts for approximately 3 percent of cancers in women, it is responsible for the most deaths of any cancer involving the f...

PubMed Articles [10364 Associated PubMed Articles listed on BioPortfolio]

Impact of community disadvantage and air pollution burden on geographic disparities of ovarian cancer survival in California.

Ovarian cancer survival varies geographically throughout California. The objective of this study is to determine the impact of living in disadvantaged communities on spatial patterns of survival dispa...

Advocacy coalitions involved in California's menu labeling policy debate: Exploring coalition structure, policy beliefs, resources, and strategies.

Advocacy coalitions often play an important role in the state health policymaking process, yet little is known about their structure, composition, and behavior. In 2008, California became the first st...

MELK expression in ovarian cancer correlates with poor outcome and its inhibition by OTSSP167 abrogates proliferation and viability of ovarian cancer cells.

Maternal embryonic leucine-zipper kinase (MELK) shows oncogenic properties in basal-like breast cancer, a cancer subtype sharing common molecular features with high-grade serous ovarian cancer. We exa...

Role of oxidative stress in epithelial ovarian cancer in Egyptian patients.

Ovarian cancer has the highest mortality rate amongst all gynecologic malignancies. 90% of the cases are epithelial ovarian cancer (EOC). Ovarian cancer associated with reduction in the serum level of...

The Role of Opportunistic Bilateral Salpingectomy Versus Tubal Occlusion or Ligation for Ovarian Cancer Prophylaxis.

Bilateral tubal ligation for sterilization has been known to decrease the risk of ovarian cancer. Recent studies have suggested that bilateral salpingectomy (BS) may be an alternative to bilateral tub...

Clinical Trials [8529 Associated Clinical Trials listed on BioPortfolio]

China Ovarian Cancer BRCA Testing Study

This is a prospective, multi-center, observational study, the primary objective is to evaluate the prevalence of gBRCA/sBRCAm in newly diagnosed ovarian cancer patients and explore ovarian...

Writing About Experiences With Ovarian Cancer

This online study aims to understand whether writing about one's experiences with ovarian cancer may be beneficial for psychological and physical wellbeing in women with a history of ovari...

M. D. Anderson Symptom Inventory - Ovarian Cancer

The goal of this behavioral research study is to learn more about the kind of symptoms that ovarian cancer patients experience. The Primary Aim is to develop and validate an ovarian-cance...

Toremifene in Treating Patients With Ovarian Cancer

RATIONALE: Estrogen can stimulate the growth of ovarian cancer cells. Hormone therapy using toremifene may fight ovarian cancer by reducing the production of estrogen. PURPOSE: Randomized...

The Development of Human Immunologic Assays Specific to Folate Receptor Antigen

Ovarian cancer has the highest mortality rate of gynecologic malignancies and the overall 5-year survival rate of ovarian cancer is only 20-30%. Additionally, the incidence of ovarian canc...

Companies [3008 Associated Companies listed on BioPortfolio]

Ovarian Cancer Coalition of Greater California

Ovarian Cancer Institute

The Ovarian Cancer Institute is a 501(c)(3) organization dedicated to ovarian cancer research. The work focuses on accurate diagnostics and improved therapeutics. Creators of a fi...

World Pancreatic Cancer Coalition

The World Pancreatic Cancer Coalition is an international group of pancreatic cancer patient advocacy groups with a mission to drive transformational change for all those affected...

National Ovarian Cancer Coalition

Avant Diagnostics, Inc.

Avant Diagnostics, Inc. is a medical diagnostic technology company that specializes in large panel biomarker screening. Our first test, OvaDx®, developed in conjunction with Ar...

More Information about "Ovarian Cancer Coalition of Greater California" on BioPortfolio

We have published hundreds of Ovarian Cancer Coalition of Greater California news stories on BioPortfolio along with dozens of Ovarian Cancer Coalition of Greater California Clinical Trials and PubMed Articles about Ovarian Cancer Coalition of Greater California for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ovarian Cancer Coalition of Greater California Companies in our database. You can also find out about relevant Ovarian Cancer Coalition of Greater California Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record